Old Web
English
Sign In
Acemap
>
authorDetail
>
Elodie Belnoue
Elodie Belnoue
Boehringer Ingelheim
Cytotoxic T cell
Cancer research
Tumor microenvironment
Cancer vaccine
Medicine
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity.
2021
Frontiers in Immunology
Matteo Rossi
Susanna Carboni
Wilma Di Berardino-Besson
Erika Riva
Marie-Laure Santiago-Raber
Elodie Belnoue
Madiha Derouazi
Show All
Source
Cite
Save
Citations (1)
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity.
2021
Nature Communications
Krishna Das
Elodie Belnoue
Matteo Rossi
Tamara Hofer
Sarah Danklmaier
Tobias Nolden
Liesa-Marie Schreiber
Katharina Angerer
Janine Kimpel
Sandra Hoegler
Bart Spiesschaert
Lukas Kenner
Dorothee von Laer
Knut Elbers
Madiha Derouazi
Guido Wollmann
Show All
Source
Cite
Save
Citations (0)
P03.02 Protein-based cancer vaccine combined with an oncolytic vaccine promotes potent antitumor immunity
2021
Journal for ImmunoTherapy of Cancer
Elodie Belnoue
Krishna Das
Matteo Rossi
Tamara Hofer
S Danklmaier
Tobias Nolden
Liesa-Marie Schreiber
Katharina Angerer
Janine Kimpel
Sandra Hoegler
Lukas Kenner
D von Laer
Knut Elbers
Guido Wollmann
Madiha Derouazi
Show All
Source
Cite
Save
Citations (0)
1